Home

PPI Platform

 

We have developed a new protein-protein interaction (PPI) small molecule inhibitor drug discovery platform.

 

Read more...

News

 

APG has signed a research cooperation agreement with the Helmholtz Institute in Munich.

 

Read more...

Pipeline

 

We have currently two drug discovery programs:

Huntington's disease and a transcription factor inhibitor for cancer treatment.

 

Read more...